Compugen (CGEN) Retained Earnings (2009 - 2025)
Compugen recorded quarterly Retained Earnings of -$453.4 million in Q4 2025, up 7.23% quarter-over-quarter from -$488.8 million in Q4 2024, and up 7.23% year-over-year from -$422.8 million in Q4 2024.
Compugen's Retained Earnings history runs 10 years deep, the most recent figure standing at -$453.4 million for Q4 2025.
- In Q4 2025, Retained Earnings rose 7.23% year-over-year to -$453.4 million; the TTM figure through Dec 2025 stood at -$453.4 million (up 7.23% YoY), while the FY2025 annual figure was -$453.4 million, up 7.23% from the prior year.
- Retained Earnings came in at -$453.4 million for Q4 2025 at Compugen, up from -$488.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $2000.0 in Q4 2023 to a low of -$488.8 million in Q4 2024.
- A 5-year average of -$364.0 million and a median of -$453.4 million in 2025 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings jumped 100.0% in 2023 and plunged 24438000.0% in 2024, its largest moves.
- Compugen's Retained Earnings stood at -$422.1 million in 2021, then retreated by 7.98% to -$455.8 million in 2022, then surged by 100.0% to $2000.0 in 2023, then slumped by 24438000.0% to -$488.8 million in 2024, then advanced by 7.23% to -$453.4 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$453.4 million, -$488.8 million, and $2000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -453.42 Mn |
| Jun 30, 2025 | -503.28 Mn |
| Dec 31, 2024 | -488.76 Mn |
| Jun 30, 2024 | -483.92 Mn |
| Dec 31, 2023 | 2,000.00 |
| Jun 30, 2023 | -474.39 Mn |
| Dec 31, 2022 | -455.77 Mn |
| Jun 30, 2022 | -440.93 Mn |
| Dec 31, 2021 | -422.08 Mn |
| Jun 30, 2021 | -407.28 Mn |
| Dec 31, 2020 | -387.88 Mn |
| Jun 30, 2020 | -371.55 Mn |
| Dec 31, 2019 | -358.18 Mn |
| Jun 30, 2019 | -345.23 Mn |
| Dec 31, 2018 | -330.84 Mn |
| Jun 30, 2018 | -318.33 Mn |
| Dec 31, 2017 | -308.24 Mn |
| Jun 30, 2017 | -289.06 Mn |
| Dec 31, 2016 | -270.97 Mn |
| Jun 30, 2016 | -254.69 Mn |
| Dec 31, 2015 | -239.46 Mn |
| Jun 30, 2015 | -232.25 Mn |
| Dec 31, 2014 | -219.30 Mn |
| Jun 30, 2014 | -212.42 Mn |
| Dec 31, 2013 | -208.20 Mn |
| Jun 30, 2013 | -200.53 Mn |
| Dec 31, 2012 | -194.12 Mn |
| Jun 30, 2012 | -185.24 Mn |
| Dec 31, 2011 | -180.49 Mn |
| Jun 30, 2011 | -172.54 Mn |
| Dec 31, 2010 | -168.49 Mn |
| Sep 30, 2010 | -166.47 Mn |
| Dec 31, 2009 | -161.28 Mn |
| Jun 30, 2009 | -157.39 Mn |